Health Check: Mesoblast shares sink despite $260m placement …

1 day ago · The placement follows Mesoblast achieving US Food and Drug Administration (FDA) approval in December for its cell therapy remestemcel-L to treat paediatric graft-versus-host …

$260
OFF

Health Check: Mesoblast Shares Sink Despite $260m Placement …

2 weeks from now

1 day ago · The placement follows Mesoblast achieving US Food and Drug Administration (FDA) approval in December for its cell therapy remestemcel-L to treat paediatric graft-versus-host …

stockhead.com.au

30%
OFF

Mesoblast Share Price Rockets 30% On Big US FDA News

2 weeks from now

Dec 19, 2024 · The market is a sea of red on Thursday but that isn't stopping the Mesoblast Ltd share price from rocketing. In morning trade, the allogeneic cellular medicines developer's …

fool.com.au

18%
OFF

Why The Mesoblast Share Price Is Diving 18% After An FDA Win

2 weeks from now

Dec 20, 2024 · The Mesoblast Ltd (ASX: MSB) share price is taking a dive today. Here’s why the biotech stock is under pressure after yesterday’s FDA win. ... Mesoblast share price rockets …

fool.com.au

77%
OFF

Up 77% In A Month! What's Going On With The Mesoblast Share …

2 weeks from now

Jan 7, 2025 · On the day that this news became public, Mesoblast shares soared a whopping 54%. The company has continued to trend upwards (barring some s poradic profit-taking) ever …

fool.com.au

38%
OFF

Mesoblast (ASX:MSB) Share Price Rockets Higher | Rask Media

2 weeks from now

Aug 14, 2020 · The Mesoblast Limited share price has soared 38% higher after the biotech business announced positive US news.. US update. The Mesoblast share price recently sank …

raskmedia.com.au

70%
OFF

2024 – Daily Crow

2 weeks from now

Mayorkas originally claimed the release rate was 70% in an interview with FOX News, only to raise that number to 85% when agents pressed him during the private meeting. Trump …

dailycrow.com

12%
OFF

Mesoblast (ASX:MSB) Share Price Jumps 12% On FDA Update

2 weeks from now

Dec 16, 2021 · The Mesoblast Limited share price is soaring today on the back of a clinical trial update. In morning trade, the company's shares are trading at $1.495, up 12%.

fool.com.au

FAQs about Health Check: Mesoblast shares sink despite $260m placement … Coupon?

Why did Mesoblast's share price skyrocket?

Biotech company Mesoblast saw its share price skyrocket after it received approval from the US Food and Drug Administration (FDA) for its cell therapy, used to treat children with complications that can occur from bone marrow transplants. ...

Will a sea of red stop Mesoblast share price from rocketing?

Learn More The market is a sea of red on Thursday but that isn't stopping the Mesoblast Ltd (ASX: MSB) share price from rocketing. In morning trade, the allogeneic cellular medicines developer's shares are up 30% to a 52-week high of $2.57. ...

What happened to Mesoblast share price after FDA announcement?

Following Thursday's release of the FDA announcement, investors sent the Mesoblast share price blasting off to close the day at an eye-popping 54.0%. Yep, that's no typo. After this kind of massive intraday gain, for a company with a market cap of at least $3 billion, it's not uncommon to see investors take some gains off the table. What now? ...

Why is the Mesoblast share price soaring?

ASX investors are sending the Mesoblast share price soaring following promising FDA news. Bernd Struben earned his BA in economics from the University of Michigan in 1991, with post-graduate studies in environmental economics at the University of Connecticut. ...